1000-467X
2013 Issue 1
Aberrant DNA methylation in cervical carcinogenesis
Hui-Juan Yang Department of Gynecologic Oncology;Fudan University Shanghai Cancer Center;Shanghai 200032;P.R.China
Hui-Juan Yang Department of Gynecologic Oncology;Fudan University Shanghai Cancer Center;Shanghai 200032;P.R.China
..............page:42-48
Cancer research in an era when epigenetics is no longer "epi"—challenges and opportunities
Qian Tao Cancer Epigenetics Laboratory;State Key Laboratory of Oncology in South China;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;Department of Clinical Oncology;The Chinese University of Hong Kong;Hong Kong and CUHK-Shenzhen Research Institute.
Qian Tao Cancer Epigenetics Laboratory;State Key Laboratory of Oncology in South China;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;Department of Clinical Oncology;The Chinese University of Hong Kong;Hong Kong and CUHK-Shenzhen Research Institute.
..............page:1-2
..............page:53
Glioma-related edema:new insight into molecular mechanisms and their clinical implications
Zhi-Xiong Lin Department of Neurosurgery;The First Affiliated Hospital;Fujian Medical University;Fuzhou;Fujian 350005;P.R.China
Zhi-Xiong Lin Department of Neurosurgery;The First Affiliated Hospital;Fujian Medical University;Fuzhou;Fujian 350005;P.R.China
..............page:49-52
Epigenetic changes in colorectal cancer
Yan Jia1;2and Mingzhou Guo11Department of Gastroenterology & Hepatology;Chinese PLA General Hospital;Beijing 100853;P.R.China;2Medical College of Nankai University;Tianjin 300071;P.R.China.
Yan Jia1;2and Mingzhou Guo11Department of Gastroenterology & Hepatology;Chinese PLA General Hospital;Beijing 100853;P.R.China;2Medical College of Nankai University;Tianjin 300071;P.R.China.
..............page:21-30
Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma
Ji-Sheng Li1;Jian-Ming Ying2;Xiu-Wen Wang1;Zhao-Hui Wang3;4;Qian Tao3;4and Li-Li Li3;4 1Department of Chemotherapy;Cancer Center;Qilu Hospital;Shandong University;Jinan;Shandong 250012;P.R.China;2Department of Pathology;Cancer Hospital & Institute;Peking Union Medical College and Chinese Academy of Medical Sciences;Beijing 100021;P.R.China;3Cancer Epigenetics Laboratory;Department of Clinical Oncology;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;The Chinese University of Hong Kong;Hong Kong and CUHK Shenzhen Research Institute;Shenzhen;Guangdong 518055;P.R.China;4Shenzhen Institutes of Advanced Technology;Chinese Academy of Sciences-CUHK;Shenzhen;Guangdong 518055;P.R.China.
Ji-Sheng Li1;Jian-Ming Ying2;Xiu-Wen Wang1;Zhao-Hui Wang3;4;Qian Tao3;4and Li-Li Li3;4 1Department of Chemotherapy;Cancer Center;Qilu Hospital;Shandong University;Jinan;Shandong 250012;P.R.China;2Department of Pathology;Cancer Hospital & Institute;Peking Union Medical College and Chinese Academy of Medical Sciences;Beijing 100021;P.R.China;3Cancer Epigenetics Laboratory;Department of Clinical Oncology;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;The Chinese University of Hong Kong;Hong Kong and CUHK Shenzhen Research Institute;Shenzhen;Guangdong 518055;P.R.China;4Shenzhen Institutes of Advanced Technology;Chinese Academy of Sciences-CUHK;Shenzhen;Guangdong 518055;P.R.China.
..............page:3-11
Recent progress in the study of methylated tumor suppressor genes in gastric cancer
Xiao-Tong Hu1and Chao He1;21Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province;2Department of Colorectal Surgery;Sir Run Run Shaw Hospital;Hangzhou;Zhejiang 310016;P.R.China.
Xiao-Tong Hu1and Chao He1;21Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province;2Department of Colorectal Surgery;Sir Run Run Shaw Hospital;Hangzhou;Zhejiang 310016;P.R.China.
..............page:31-41
Aberrant promoter CpG methylation and its translational applications in breast cancer
Ting-Xiu Xiang1;Ying Yuan1;Li-Li Li2;3;Zhao-Hui Wang2;3;Liang-Ying Dan1;Yan Chen3;Guo-Sheng Ren1;Qian Tao1;2;31Molecular Oncology and Epigenetics Laboratory;The First Affiliated Hospital of Chongqing Medical University;Chongqing 400016;P.R.China;2Shenzhen Institutes of Advanced Technology;Chinese Academy of Sciences-CUHK;Shenzhen;Guangdong 518055;P.R.China;3Cancer Epigenetics Laboratory;Department of Clinical Oncology;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;The Chinese University of Hong Kong;Hong Kong and CUHK Shenzhen Research Institute;Shenzhen;Guangdong 518055;P.R.China.
Ting-Xiu Xiang1;Ying Yuan1;Li-Li Li2;3;Zhao-Hui Wang2;3;Liang-Ying Dan1;Yan Chen3;Guo-Sheng Ren1;Qian Tao1;2;31Molecular Oncology and Epigenetics Laboratory;The First Affiliated Hospital of Chongqing Medical University;Chongqing 400016;P.R.China;2Shenzhen Institutes of Advanced Technology;Chinese Academy of Sciences-CUHK;Shenzhen;Guangdong 518055;P.R.China;3Cancer Epigenetics Laboratory;Department of Clinical Oncology;Sir YK Pao Center for Cancer and Li Ka Shing Institute of Health Sciences;The Chinese University of Hong Kong;Hong Kong and CUHK Shenzhen Research Institute;Shenzhen;Guangdong 518055;P.R.China.
..............page:12-20